Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetravalent Inactivated Enterovirus Vaccine in Healthy Adults and Children
NCT06754384Phase 2Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Jan 2025
- Primary completion
- Dec 2025
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Tetravalent inactivated enterovirus vaccine in HIV-associated central nervous system involvement (HAND), herpangina, sponsored by Sinovac Biotech Ltd.. Started Jan 2025; status: completed.
02
Drugs
Tetravalent inactivated enterovirus vaccine
03
Conditions
HIV-associated central nervous system involvement (HAND)herpangina
Beyond the preview
Go deeper on NCT06754384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06754384.